Orion Portfolio Solutions LLC Reduces Stock Position in Solventum Co. (NYSE:SOLV)

Orion Portfolio Solutions LLC decreased its position in Solventum Co. (NYSE:SOLV) by 3.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 18,317 shares of the company’s stock after selling 561 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Solventum were worth $1,210,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Modus Advisors LLC purchased a new stake in shares of Solventum in the fourth quarter valued at $25,000. Stonebridge Financial Group LLC acquired a new stake in Solventum in the 4th quarter worth about $26,000. Crews Bank & Trust purchased a new stake in Solventum in the 4th quarter valued at about $32,000. Synergy Asset Management LLC acquired a new position in shares of Solventum during the 4th quarter valued at about $35,000. Finally, Spire Wealth Management purchased a new position in shares of Solventum during the 4th quarter worth about $37,000.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. The Goldman Sachs Group boosted their target price on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a report on Monday, March 3rd. Piper Sandler upped their price objective on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a report on Friday, February 28th. Bank of America increased their target price on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 26th. Morgan Stanley boosted their price target on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 5th. Finally, Mizuho raised their price objective on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $79.86.

Solventum Trading Down 5.7 %

Shares of SOLV opened at $66.22 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The stock has a market cap of $11.45 billion and a PE ratio of 24.08. The stock’s 50-day moving average is $75.42 and its two-hundred day moving average is $71.95.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.